The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 781-787

  Wang, Xiaofei ^a   Nickenig, Georg ^a   Murphy, T J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIBUTYRYL CYCLIC GMP; FORSKOLIN; ISOPRENALINE; MESSENGER RNA; PHOSPHODIESTERASE INHIBITOR; PHOSPHORUS 32; TRITIUM;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RNA DEGRADATION; RNA TRANSCRIPTION; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE;

EID: 0030733076     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.781     Document Type: Article

References (40)

1. Sachs, A. B. Messenger RNA degradation in eukaryotes. Cell 74:413-421 (1993).
2. Peltz, S. W., G. Brewer, P. Bernstein, P. A. Hart, and J. Ross. Regulation of mRNA turnover in eukaryotic cells. Grit. Rev. Eukaryotic Gene. Expr. 1:99-126 (1991).
3. Schiavi, S. C., J. G. Belasco, and M. E. Greenberg. Regulation of protooncogene mRNA stability. Biochim. Biophys. Acta 1114:95-106 (1992).
4. Klausner, R. D., T. A. Rouault, and J. B. Harford. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72:19-28 (1993).
5. Mullner, E. W., and L. C. Kuhn. A stem-loop in the 3′ untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell 53:815-825 (1988).
6. 2) control mammalian iron metabolism by different pathways. Mol. Cell Biol. 16:3781-8 (1996).
7. Ross, J. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450 (1995).
8. Lee, N. H., J. Earle-Hughes, and C. M. Fraser. Agonist-mediated destabilization of m1 muscarinic acetylcholine receptor mRNA. J. Biol. Chem. 269:4291-4298 (1994).
9. Narayanan, C. S., J. Fujimoto, E. Geras-Raaka, and M. C. Gershengorn. Regulation by thyrotropin-releasing hormone (TRH) of TRH receptor mRNA degradation in rat pituitary GH3 cells. J. Biol. Chem. 267:17296-303 (1992).
10. 1b-adrenergic receptor mRNA in vascular smooth muscle cells. J. Biol. Chem. 269:1705-1710 (1994).
11. Hadcock, J. R., and C. C. Malbon. Down-regulation of β2-adrenergic receptors: agonist-induced reduction in receptor mRNA levels. Proc. Natl. Acad. Sci. USA 85:5021-5025 (1988).
12. Hadcock, J. R., H.-Y. Wang, and C. C. Malbon. Agonist induced destabilization of β-adrenergic receptor mRNA: attenuation of glucocorticoid-induced up-regulation of β-adrenergic receptors. J. Biol. Chem. 264: 19928-19933 (1989).
13. r 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNA. J. Biol. Chem 267: 24103-24108 (1992).
14. r 35,000 β-adrenergic receptor mRNA-binding protein induced by agonists requires both an AUUUA pentamer and U-rich domains for RNA recognition. J. Biol. Chem. 268:25769-25775 (1993).
15. r 35,000 β-adrenergic receptor mRNA-binding protein binds transcripts of G-protein-linked receptors which undergo agonist-induced destabilization. J. Biol. Chem. 270:12787-12793 (1995).
16. Collins, S., M. Bouvier, M. A. Bolanowski, M. G. Caron, and R. J. Lefkowitz. cAMP stimulates transcription of the β2-adrenergic receptor gene in response to short-term agonist exposure. Proc. Natl. Acad. Sci. USA 86: 4853-4857 (1989).
17. Hosoda, K., L. R. Fitzgerald, V. A. Vaidya, G. K. Feussner, P. H. Fishman, and R. S. Duman. Regulation of β2-adrenergic receptor mRNA and gene transcription in rat C6 glioma cells: effects of agonist, forskolin, and protein synthesis inhibition. Mol. Pharmacol. 48:206-211 (1995).
18. Heaton, J. H., S. Kathju, and T. D. Gelehrter. Transcriptional and post-transcriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol. Endocrinol. 6:53-60 (1992).
19. Fossom, L. H., C. R. Sterling, and A. W. Tank. Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid. Mol. Pharmacol. 42:898-908 (1992).
20. Nickenig, G., and T. J. Murphy. Down-regulation by growth factors of vascular angiotensin receptor gene expression. Mol. Pharmacol. 46:653-659 (1994).
21. Nickenig, G., and T. J. Murphy. Enhanced ATI receptor mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol. Pharmacol. 50:743-751 (1996).
22. Lassegue, B., R. W. Alexander, G. Nickenig, M. Clark, T. J. Murphy, and K. K. Griendling. Angiotensin II down-regulates the vascular AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence of homologous and heterologous regulation. Mol. Pharmacol. 48:601-609 (1995).
23. Chen, X., J. Nishimura, J. Hasna, S. Kobayashi, T. Shikasho, and H. Kanaide. Protein kinase C and protein kinase A regulate the expression of angiotensin II receptor mRNA in smooth muscle cells. Eur. J. Pharmacol. 267:175-183 (1994).
24. Shimizu, H., J. W. Daly, and C. R. Creveling. A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J. Neurochem. 16:1609-1619 (1969).
25. Graves, L. M., K. E. Bornfeldt, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 271:505-511 (1996).
26. Linial, M., N. Gunderson, and M. Grouding. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science (Washington D. C.) 230:1126-1132 (1985).
27. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Bernstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond.) 351:233-236 (1991).
28. Yankulov, K., K. Yamashita, R. Roy, J. M. Egly, and D. L. Bentley. The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase. J. Biol. Chem. 270:23922-23925 (1995).
29. Shi, H., and D. L. Segaloff. A role for increased lutropin/choriogonadotropin receptor (LHR) gene transcription in the follitropin-stimulated induction of the LHR in granulosa cells. Mol. Endocrinol. 9:734-44 (1995).
30. Pilkis, S. J., and D. K. Granner. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 54:885-909 (1992).
31. Pirson, I., K. Coulonval, F. Lamy, and J. E. Dumont. c-Myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes. J. Cell Physiol. 168:59-70 (1996).
32. Margana, R. K., and V. Boggaram. Transcription and mRNA stability regulate developmental and hormonal expression of rabbit surfactant protein B gene. Am. J. Physiol. 268:L481-L490 (1995).
33. Hadcock, J. R., M. Ros, and C. C. Malbon. Agonist regulation of β-adrenergic receptor mRNA: analysis in S49 mouse lymphoma mutants. J. Biol. Chem. 13956-13961 (1989).
34. Kono, T., and F. W. Barham. Effects of insulin on the levels of adenosine 3′:5′-monophosphate and lipolysis in isolated rat epididymal fat cells. J. Biol. Chem. 248:7417-7426 (1973).
35. Klein, D. C., M. J. Buda, C. L. Kapoor, and G. Krishna. Pineal serotonin N-acetyltransferase activity: abrupt decrease in adenosine 3′,5′-monophosphate may be signal for 'turnoff.' Science (Washington D. C.) 199:309-311 (1978).
36. Hayes, J. S., and L. L. Brunton. Functional compartments in cyclic nucleotide action. J. Cyclic Nucleotide Res. 8:1-16 (1982).
37. Walsh, D. A., D. B. Glass, and R. D. Mitchell. Substrate diversity of the cAMP-dependent protein kinase: regulation based upon multiple binding interactions. Curr. Opin. Cell. Biol. 4:241-251 (1992).
38. Dubois, M.-F., V. T. Nguyen, S. Bellier, and O. Bensaude. Inhibitors of transcription such as 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J. Biol. Chem. 269:13331-13336 (1994).
39. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267-5272 (1990).
40. Garland, L. G. Protein kinase C inhibitors are not selective. Trends Pharm. Sci. 8:334 (1987).